May 9th, 2017
ASHLAND, VIRGINIA and ABINGDON, OXFORDSHIRE U.K. -- The Biorenewable Deployment Consortium (BDC) honored Green Biologics, Inc. with the organization’s Spring 2017 Commercialization Achievement Award at its spring meeting in Des Moines on May 2, 2017.
Recognition for Renewable Alternatives
Green Biologics is recognized for its leadership in the biorenewable industry and successful commercialization of renewable alternatives to n-butanol, acetone and its associated derivatives.
BDC Chairman and Co-Founder Ben Thorp said:
“The Biorenewable Deployment Consortium is proud to honor Green Biologics with its Spring 2017 Commercialization Achievement Award. Green Biologics is a great example of a company that is effectively using its technology platform to produce a wide range of sustainable feedstocks into high performance green chemicals and industrial products. Its commercial plant in Little Falls, MN is the reason that BDC has recognized Green Biologics and awarded its global team for its continued success.”
Global Network of Partners
Green Biologics officially began customer shipments at its first commercial facility in Little Falls, MN, in December 2016, marking the culmination of a years’-long effort to create a robust, global network of customers and partners.
These relationships have enabled the company to bring its 100 percent bio-based products to numerous downstream markets and specialty applications. As a result, Green Biologics has further strengthened its position as a global renewable specialty chemicals company, and reinforced its ability to meet the needs of today’s producers and consumers, who are demanding environmentally conscious alternatives to longstanding products.
Green Biologics’ Global VP Business Development, who received the award on behalf of the company, Tim Staub said:
“We’re pleased to be recognized by the Biorenewable Deployment Consortium for these achievements. Our global team’s tireless efforts and dedication to a greener, cleaner tomorrow made all that we have accomplished possible, and we thank all involved for their hard work. It makes us very proud to follow in the footsteps of companies like DuPont Industrial Biosciences, which received this honor last year, and we’ll continue to work hard to bring new products and innovative solutions to market.”
About the Biorenewable Deployment Consortium (BDC)
BDC (www.biorenewabledc.org), since 2006, has worked to bring together like minded companies to share ideas and partner to deploy bio-processes that can be economic in the long run without government subsidy, by holding two symposiums a year for its members, where leading edge information from various bio-companies is shared and tours are made of bio-facilities. BDC also acts as a resource to members and works to broker partnerships that can lead to the deployment of economic demonstration and commercial facilities. BDC recognizes the need for low cost feedstock, cost effective measures such as integration of processes, high value products, and good management to achieve the economics needed for success.
About Green Biologics
Green Biologics Ltd (GBL) is a renewable specialty chemicals company based in Abingdon, England with a wholly owned U.S. operating company, Green Biologics Inc., based in Ashland, Virginia. GBL’s Clostridium fermentation platform converts a wide range of sustainable feedstocks into high performance green chemicals such as n-butanol, acetone, and through chemical synthesis, derivatives of butanol and acetone used by a growing global consumer and industrial products customer base.
The platform combines advanced high productivity fermentation with superior-performing proprietary Clostridium microbial biocatalysts and synthetic chemistry to produce a pipeline of high value green chemicals with optimal performance in downstream formulations.